Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 147

1.

Forecasting the In Vivo Behavior of Radiocontaminants of Unknown Physicochemical Properties Using a Simple In Vitro Test.

Griffiths NM, Coudert S, Moureau A, Laroche P, Angulo JF, Van der Meeren A.

Health Phys. 2016 Aug;111(2):93-9. doi: 10.1097/HP.0000000000000441.

PMID:
27356051
2.

Penetration and decontamination of americium-241 ex vivo using fresh and frozen pig skin.

Tazrart A, Bolzinger MA, Moureau A, Molina T, Coudert S, Angulo JF, Briancon S, Griffiths NM.

Chem Biol Interact. 2016 May 24. pii: S0009-2797(16)30197-1. doi: 10.1016/j.cbi.2016.05.027. [Epub ahead of print]

PMID:
27234047
3.

Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action.

Grémy O, Laurent D, Coudert S, Griffiths NM, Miccoli L.

Radiat Res. 2016 Jun;185(6):568-79. doi: 10.1667/RR14193.1.

PMID:
27195610
4.

Photo-convertible fluorescent proteins as tools for fresh insights on subcellular interactions in plants.

Griffiths N, Jaipargas EA, Wozny MR, Barton KA, Mathur N, Delfosse K, Mathur J.

J Microsc. 2016 Aug;263(2):148-57. doi: 10.1111/jmi.12383.

PMID:
26820914
5.

Identification and therapeutic potential of a vitronectin binding region of meningococcal msf.

Hill DJ, Griffiths NJ, Borodina E, Andreae CA, Sessions RB, Virji M.

PLoS One. 2015 Mar 31;10(3):e0124133. doi: 10.1371/journal.pone.0124133.

PMID:
25826209
6.

Macrophages as key elements of Mixed-oxide [U-Pu(O2)] distribution and pulmonary damage after inhalation?

Van der Meeren A, Moureau A, Griffiths NM.

Int J Radiat Biol. 2014 Nov;90(11):1095-103. doi: 10.3109/09553002.2014.943848.

PMID:
25029673
7.

Combined drug and surgery treatment of plutonium-contaminated wounds: indications obtained using a rodent model.

Griffiths NM, Coudert S, Wilk JC, Renault D, Angulo JF, Van der Meeren A.

Health Phys. 2014 Jun;106(6):638-44. doi: 10.1097/HP.0000000000000088.

PMID:
24776894
8.

Increased retention of americium in kidneys as compared with plutonium in an actinide wound contamination model in the rat.

Griffiths NM, Coudert S, Molina T, Wilk JC, Renault D, Berard P, Van der Meeren A.

Int J Radiat Biol. 2014 Nov;90(11):1019-24. doi: 10.3109/09553002.2014.905723.

PMID:
24650071
9.

Actinide handling after wound entry with local or systemic decorporation therapy in the rat.

Griffiths NM, Coudert S, Renault D, Wilk JC, Van der Meeren A.

Int J Radiat Biol. 2014 Nov;90(11):989-95. doi: 10.3109/09553002.2014.886797.

PMID:
24456546
10.

Expectations of parents on low incomes and therapists who work with parents on low incomes of the first therapy session.

Andrews F, Griffiths N, Harrison L, Stagnitti K.

Aust Occup Ther J. 2013 Dec;60(6):436-44. doi: 10.1111/1440-1630.12044.

PMID:
24299483
11.

A randomised controlled trial of a brief online mindfulness-based intervention.

Cavanagh K, Strauss C, Cicconi F, Griffiths N, Wyper A, Jones F.

Behav Res Ther. 2013 Sep;51(9):573-8. doi: 10.1016/j.brat.2013.06.003.

PMID:
23872699
12.

The development and implementation of a hospital based paediatric orthopaedic nursing transition program.

Griffiths N, Houghton K.

J Pediatr Nurs. 2013 Nov-Dec;28(6):e50-6. doi: 10.1016/j.pedn.2012.12.009.

PMID:
23376207
13.

Internal contamination by actinides after wounding: a robust rodent model for assessment of local and distant actinide retention.

Griffiths NM, Wilk JC, Abram MC, Renault D, Chau Q, Helfer N, Guichet C, Van der Meeren A.

Health Phys. 2012 Aug;103(2):187-94. doi: 10.1097/HP.0b013e31825aa202.

PMID:
22951478
14.

Plutonium behavior after pulmonary administration according to solubility properties, and consequences on alveolar macrophage activation.

Van der Meeren A, Gremy O, Renault D, Miroux A, Bruel S, Griffiths N, Tourdes F.

J Radiat Res. 2012;53(2):184-94.

PMID:
22510590
15.

Change management: talking about a revolution.

Griffiths N.

Health Serv J. 2012 Jan 19;122(6290):24-5. No abstract available.

PMID:
22393866
16.

Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance.

Griffiths NJ, Hill DJ, Borodina E, Sessions RB, Devos NI, Feron CM, Poolman JT, Virji M.

Mol Microbiol. 2011 Dec;82(5):1129-49. doi: 10.1111/j.1365-2958.2011.07876.x.

PMID:
22050461
17.

Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist.

McKay S, Griffiths NH, Butters PA, Thubron EB, Hardingham GE, Wyllie DJ.

Br J Pharmacol. 2012 Jun;166(3):924-37. doi: 10.1111/j.1476-5381.2011.01748.x.

PMID:
22022974
18.

Hospital landscape. Building bridges to improvement.

Drew J, Revington T, Goldman M, Griffiths N.

Health Serv J. 2011 Mar 24;121(6249):30-1. No abstract available.

PMID:
21548534
19.

Hospital landscape. Why curiosity is a winning attitude.

Griffiths N, Drew J, Goldman M.

Health Serv J. 2011 Feb 3;121(6242):24-5. No abstract available.

PMID:
21446277
20.

The hospital landscape. Seeing the wood for the trees.

Griffiths N, Drew J, Goldman M.

Health Serv J. 2010 Dec 2;120(6235):22-3. No abstract available.

PMID:
21254488
Items per page

Supplemental Content

Loading ...
Support Center